Literature DB >> 7931867

Reasons for discharge from methadone maintenance for addicts at high risk of HIV infection or transmission.

C E Grella1, M D Anglin, S E Wugalter, R Rawson, A Hasson.   

Abstract

This article reports on a methadone maintenance program that had the goal of retaining in treatment heroin addicts at high risk of HIV infection and/or transmission. Subjects were recruited from four-high-risk target groups and randomly assigned to either an enhanced or standard methadone maintenance group. The analysis examined predictors of any type of discharge, negative discharge, and circumstantial discharge. Discharge for any reason was more likely for younger individuals, sex industry workers, and high-risk sex partners. Legal supervision at intake and coercion into treatment reduced the probability of discharge for any reason. HIV-positive individuals were more likely to discharge for circumstantial reasons than negative reasons. The probability of circumstantial discharge was increased for males, individuals reporting suicidal ideation, and those scoring higher on an impulse expression scale. The likelihood of circumstantial discharge was decreased for individuals who reported more sources of legal income or who lived someone using illegal drugs. Participation in the enhanced treatment group appeared to reduce the probability of negative, compared with circumstantial, discharge. The findings should assist methadone treatment providers in targeting individuals at high probability of discharge for special efforts to increase treatment retention and to reengage them back into treatment after discharge, as part of a harm-reduction strategy to minimize risks of HIV infection and/or transmission.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7931867     DOI: 10.1080/02791072.1994.10472270

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  5 in total

Review 1.  Black-white disparities in HIV/AIDS: the role of drug policy and the corrections system.

Authors:  Kim M Blankenship; Amy B Smoyer; Sarah J Bray; Kristin Mattocks
Journal:  J Health Care Poor Underserved       Date:  2005-11

2.  Parole officer-parolee relationships and HIV risk behaviors during community supervision.

Authors:  Traci C Green; Jennifer Johnson; Magdalena Harrington; Enrique R Pouget; Anne G Rhodes; Faye S Taxman; Daniel J O'Connell; Steven S Martin; Michael Prendergast; Peter D Friedmann
Journal:  AIDS Behav       Date:  2013-10

3.  Association between clinically recognized suicidality and subsequent initiation or continuation of medications for opioid use disorder.

Authors:  Madeline C Frost; Julie E Richards; John R Blosnich; Eric J Hawkins; Judith I Tsui; E Jennifer Edelman; Emily C Williams
Journal:  Drug Alcohol Depend       Date:  2022-06-03       Impact factor: 4.852

4.  Improvements in outcomes in methadone patients on probation/parole regardless of counseling early in treatment.

Authors:  Sharon M Kelly; Kevin E Oʼgrady; Jerome H Jaffe; Devang Gandhi; Robert P Schwartz
Journal:  J Addict Med       Date:  2013 Mar-Apr       Impact factor: 3.702

5.  Buprenorphine Treatment for Probationers and Parolees.

Authors:  Michael S Gordon; Timothy W Kinlock; Robert P Schwartz; Kathryn A Couvillion; Laura J Sudec; Kevin E O'Grady; Frank J Vocci; Hamin Shabazz
Journal:  Subst Abus       Date:  2014-04-04       Impact factor: 3.716

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.